BeNeLux Partnership

SE | NO | DK : A New Era in Regenerative Medicine Distribution

We are thrilled to announce the beginning of a new era in the distribution of Regen Lab products across Sweden, Norway, and Denmark. This exciting development is made possible through our esteemed partnerships with New Medic Era AB in Sweden and Medu in Norway-Denmark.

Effective immediately, Medu AS and Medicera are the sole valid distribution channels for Regen Lab product supply in these regions.

Distributors Informations

Medicera | Sweden

Point of contact (sales):
Schabnam Parhez :
schabnam.parhez@medicera.com

Medu AS | Norway-Denmark.

Point of contact (sales):
Thorbjørn Torp :
tt@medu.no
Herman Falkum-Hansen :
hfh@medu.no

Please note that our agreements with former distribution partners, Adcare and Astomed, have formally ended. They are no longer authorized to distribute Regen Lab products, and all supplies from them should have ceased today to conform with the essential terms and requirements for conform marketing and sales as mandated by competent laws and authorities.

Together, we are committed to advancing the principles of regenerative medicine, leveraging the expertise and professionalism of our well-established partners. This collaboration marks a significant milestone in our mission to provide innovative and effective solutions in the field of regenerative medicine.

About Us

Since 2003, Regen Lab SA has specialized in designing and manufacturing high-quality medical devices for cell therapies and the preparation of autologous platelet-rich plasma (PRP) from the patient's own blood for bedside procedures.

More

Milestones

2003 - Foundation
2010 - RegenKit first approval in bone graft
2013 - A new state-of-theart laboratory in Lausanne
2014 - Cellular Matrix first approval
2015 - Launch of Cellular Matrix in Europe

More

Vision

Founded in 2003, Regen Lab has become a global reference thanks to its commitment to innovation, quality, and the effectiveness of its therapeutic solutions. Here’s how we have transformed the medical landscape over the past two decades.

More

RegenPRP™

RegenPRP™ is a medical treatment that uses platelet-rich plasma from the patient's own blood to enhance and tissue regeneration.

More

RegenPRP™ - HA

RegenPRP™ - HA combination is an innovative treatment combining platelet-rich plasma (PRP) and hyaluronic acid to improve tissue regeneration and healing.

More

RegenPRP™ - ATS

RegenPRP™ combined with ATS (Autologous Thrombin Serum) is an advanced approach to tissue regeneration that uses autologous thrombin-enriched platelet-rich plasma (PRP) to maximise healing effects.

More

RegenExtracell®

RegenExtracell is an innovative tissue regeneration treatment using an extracellular matrix enriched with platelet-rich plasma (PRP).

More

Hyaluronic Acid

Coming Soon

Regulatory

Manufacturers of medical devices based outside the EU must designate an Authorized Representative (EC-REP) established within the EU in order to meet the CE requirements for placing medical devices on the EU market.

More

Quality Management

Regen Lab Quality System Management ensures the consistency of our products quality in total GMP compliance.

Our production facility rooms atmosphere is monitored to satisfy non-pyrogenic medical devices manufacturing.

More

Patents

As a leader in the PRP&HA regenerative field and as an innovation-driven company, Regen Lab SA has devoted important resources since 2004 to put on the market pioneering and diversified products constituting a complete set of tools/technologies for the medical community.

More